Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...
ORR 35.8% overall, 37.5% in second-/third-line, and 47.1% in light/nonsmokers, with median DOR not reached in key subsets.
"This really rocked me," the music icon — who will release his 33rd studio album, ‘What a Time,’ on June 5 — says of going ...
Lung cancer is often misunderstood, leading to delayed diagnosis and missed treatment opportunities. Experts debunk myths ...
In this video, Lukas Delasos, DO, discusses the accelerated approval of zongertinib as an initial treatment option for adults ...
The 2026 IASLC Targeted Therapies in Lung Cancer meeting brought together leading oncologists, surgeons, and patient ...
CLEVELAND, Ohio — A drug developed decades ago by an Ohio University professor shows new potential to make ...
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...
The Grammy-winning entertainer won't need chemotherapy or radiation and is set to release a new album in June while ...
UCHealth Parkview has announced that it's expanding access to advanced lung diagnostics in southern Colorado with the Ion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results